|Bid||65.23 x 300|
|Ask||65.67 x 400|
|Day's Range||64.01 - 65.67|
|52 Week Range||40.58 - 69.53|
|PE Ratio (TTM)||-16.08|
|Earnings Date||Oct 30, 2017 - Nov 3, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||78.46|
Preclinical Research Demonstrating a Direct Relationship Between Misfolded Light Chain Toxicity and NT-proBNP Production Clinical Outcomes Research Showing a Correlation between NT-proBNP Response and ...
A Relative Strength Rating upgrade for Prothena shows improving technical performance.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Prothena Corp. Plc Here are 5 ETFs with the largest exposure to PRTA-US. Comparing the performance and risk of Prothena Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)